Expression of Human Full-Length and Minidystrophin in Transgenic MDX Mice: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Human Molecular Genetics - United Kingdom
doi 10.1093/hmg/4.8.1245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Immune Responses to Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

Long-Term Expression of Full-Length Human Dystrophin in Transgenic MDX Mice Expressing Internally Deleted Human Dystrophins

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Comparison of Experimental Protocols of Physical Exercise for MDX Mice and Duchenne Muscular Dystrophy Patients

Journal of Neuromuscular Diseases
Neurology
2015English

Duchenne Muscular Dystrophy Gene Therapy: Lost in Translation?

Research and Reports in Biology
2011English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Progress Toward Gene Therapy of Duchenne Muscular Dystrophy

Seminars in Neurology
Neurology
1999English

Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in MDX/mTR Mice

Cell
BiochemistryGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy